A case of chemotherapy efficacy with atezolizumab plus bevacizumab dose reduction for hepatocellular carcinoma against nasal hemorrhage as bevacizumab-related adverse event
{"title":"A case of chemotherapy efficacy with atezolizumab plus bevacizumab dose reduction for hepatocellular carcinoma against nasal hemorrhage as bevacizumab-related adverse event","authors":"Keisuke Sakaguchi, Masayuki Miyazaki, Yuichi Tachibana, Akihiro Ueda, Tetsuro Akashi","doi":"10.2957/kanzo.65.31","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":17925,"journal":{"name":"Kanzo","volume":"121 13","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Kanzo","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2957/kanzo.65.31","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
